Lanean...
The Roles of Interleukin-6 in the Pathogenesis of Rheumatoid Arthritis
Several clinical studies have demonstrated that the humanized anti-interleukin-6 (IL-6) receptor antibody tocilizumab (TCZ) improves clinical symptoms and prevents progression of joint destruction in rheumatoid arthritis (RA). However, the precise mechanism by which IL-6 blockade leads to the improv...
| Egile Nagusiak: | , |
|---|---|
| Formatua: | Online Artikulua Texto |
| Hizkuntza: | English |
| Argitaratua: |
Hindawi Publishing Corporation
2011
|
| Gaiak: | |
| Sarrera elektronikoa: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3199948/ https://www.ncbi.nlm.nih.gov/pubmed/22046525 http://dx.doi.org/10.1155/2011/765624 |